Semi Lim

607 total citations
18 papers, 480 citations indexed

About

Semi Lim is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Semi Lim has authored 18 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Semi Lim's work include Peptidase Inhibition and Analysis (4 papers), Ubiquitin and proteasome pathways (4 papers) and Computational Drug Discovery Methods (3 papers). Semi Lim is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Ubiquitin and proteasome pathways (4 papers) and Computational Drug Discovery Methods (3 papers). Semi Lim collaborates with scholars based in South Korea, United States and Canada. Semi Lim's co-authors include Ki Won Lee, Sanguine Byun, Zigang Dong, Lee Farrand, Hyong Joo Lee, Sung‐Hoon Kim, Dae Gyu Kim, Ann M. Bode, Ji‐Man Park and Eunjung Lee and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Semi Lim

14 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Semi Lim South Korea 11 351 92 62 45 36 18 480
Hina Amin India 14 253 0.7× 93 1.0× 52 0.8× 41 0.9× 34 0.9× 19 438
Nikhil Vad United States 10 246 0.7× 72 0.8× 56 0.9× 51 1.1× 58 1.6× 14 420
Souneek Chakraborty India 15 264 0.8× 107 1.2× 69 1.1× 45 1.0× 37 1.0× 21 433
Hui‐Jye Chen Taiwan 13 379 1.1× 98 1.1× 72 1.2× 25 0.6× 36 1.0× 23 599
Kangdong Liu China 15 405 1.2× 121 1.3× 101 1.6× 36 0.8× 33 0.9× 44 644
Hyeong Sim Choi South Korea 13 257 0.7× 110 1.2× 78 1.3× 19 0.4× 49 1.4× 20 421
Munju Cho South Korea 11 447 1.3× 123 1.3× 68 1.1× 63 1.4× 20 0.6× 14 638
Ewa Totoń Poland 15 356 1.0× 63 0.7× 68 1.1× 37 0.8× 97 2.7× 38 558
Kuei-Li Lin Taiwan 12 284 0.8× 119 1.3× 60 1.0× 27 0.6× 52 1.4× 13 503
Jin-Jin Lin Taiwan 7 288 0.8× 93 1.0× 51 0.8× 34 0.8× 39 1.1× 9 552

Countries citing papers authored by Semi Lim

Since Specialization
Citations

This map shows the geographic impact of Semi Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semi Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semi Lim more than expected).

Fields of papers citing papers by Semi Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Semi Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semi Lim. The network helps show where Semi Lim may publish in the future.

Co-authorship network of co-authors of Semi Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Semi Lim. A scholar is included among the top collaborators of Semi Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Semi Lim. Semi Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
3.
Kim, Dae Gyu, Semi Lim, Yuno Lee, et al.. (2021). Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2–Depleted Splice Variant of Aminoacyl–Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70. Journal of Pharmacology and Experimental Therapeutics. 379(3). 358–371. 3 indexed citations
4.
Kim, Jisook, Hyunjin Park, Joo‐Yun Byun, et al.. (2021). Abstract 1474: Antitumor activity of belvarafenib in melanoma brain metastasis and NRAS mutation melanoma models. Cancer Research. 81(13_Supplement). 1474–1474. 1 indexed citations
5.
Kim, Dae Gyu, Nam Hoon Kwon, Semi Lim, et al.. (2020). An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody. Biomolecules. 10(6). 820–820.
6.
Kim, Dae Gyu, Deepak Bhattarai, Minkyoung Kim, et al.. (2020). Synthesis and Structure–Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy. Journal of Medicinal Chemistry. 63(10). 5139–5158. 19 indexed citations
7.
Kim, Dae Gyu, et al.. (2020). Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2. Molecules. 25(12). 2763–2763. 12 indexed citations
8.
Lee, Seungbeom, Dae Gyu Kim, Kyeojin Kim, et al.. (2020). 2-Aminophenylpyrimidines as Novel Inhibitors of Aminoacyl-tRNA Synthetase Interacting Multifunctional Protein 2 (AIMP2)-DX2 for Lung Cancer Treatment. Journal of Medicinal Chemistry. 63(8). 3908–3914. 7 indexed citations
9.
Lim, Semi, Dae Gyu Kim, & Sung‐Hoon Kim. (2019). ERK-dependent phosphorylation of the linker and substrate-binding domain of HSP70 increases folding activity and cell proliferation. Experimental & Molecular Medicine. 51(9). 1–14. 27 indexed citations
10.
Lim, Semi, et al.. (2019). Trends in Domestic and Foreign Studies on the Effect of Preventing Cervical Cancer Program in Parents. The Journal of the Korea Contents Association. 19(2). 223–230.
11.
Lim, Semi, Dae Gyu Kim, Ameeq Ul Mushtaq, et al.. (2019). Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. Nature Chemical Biology. 16(1). 31–41. 38 indexed citations
12.
Byun, Sanguine, Seung Ho Shin, Ji‐Man Park, et al.. (2016). Sulforaphene suppresses growth of colon cancer‐derived tumors via induction of glutathione depletion and microtubule depolymerization. Molecular Nutrition & Food Research. 60(5). 1068–1078. 43 indexed citations
13.
Lee, Ji-Hyun, Semi Lim, Tae‐Bum Kim, et al.. (2015). PharmDB-K: Integrated Bio-Pharmacological Network Database for Traditional Korean Medicine. PLoS ONE. 10(11). e0142624–e0142624. 14 indexed citations
14.
Byun, Sanguine, Semi Lim, Ji Young Mun, et al.. (2015). Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways. Journal of Biological Chemistry. 290(39). 23553–23562. 14 indexed citations
15.
Byun, Sanguine, Sungyoung Lee, Ji‐Hoon Lee, et al.. (2013). USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer. Clinical Cancer Research. 19(14). 3894–3904. 110 indexed citations
16.
Farrand, Lee, Sanguine Byun, Ji Young Kim, et al.. (2013). Piceatannol Enhances Cisplatin Sensitivity in Ovarian Cancer via Modulation of p53, X-linked Inhibitor of Apoptosis Protein (XIAP), and Mitochondrial Fission. Journal of Biological Chemistry. 288(33). 23740–23750. 86 indexed citations
17.
Hwang, Jeong Ah, Mun Kyung Hwang, Yongwoo Jang, et al.. (2013). 20-O-β-d-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginseng, inhibits colon cancer growth by targeting TRPC channel-mediated calcium influx. The Journal of Nutritional Biochemistry. 24(6). 1096–1104. 38 indexed citations
18.
Byun, Sanguine, Ji‐Man Park, Eunjung Lee, et al.. (2012). Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis. 34(2). 397–405. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026